UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:
As previously announced, the shareholders resolved at the Annual General Meeting held on 26 April 2012 to withdraw 6,381,983 shares, which had been repurchased under the company’s re-purchase program. Following withdrawal of these shares the number of outstanding shares and votes amounts to 73,255,705 as of 31 May 2012.
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 9.00 on 5 June 2012.
About Biotage
Biotage offers solutions, knowledge and experience
in the areas of analytical chemistry and medicinal chemistry. The
customers include the world’s largest pharmaceutical and biotech
companies, and leading academic institutes. The company is headquartered
in Uppsala and has offices in the US, UK, China and Japan. Biotage has
270 employees and had sales of 428.4 MSEK in 2011. Biotage is listed on
the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com
This information was brought to you by Cision http://www.cisionwire.com